cbdMD (YCBD) Share-based Compensation Growth (1y) (2018 - 2025)
cbdMD (YCBD) Share-based Compensation Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -96.95% |
| Sep 30, 2025 | 4,146.34% |
| Sep 30, 2024 | 136.78% |
| Sep 30, 2023 | -106.71% |
| Jun 30, 2023 | -97.91% |
| Mar 31, 2023 | -83.94% |
| Dec 31, 2022 | -91.46% |
| Sep 30, 2022 | 92.84% |
| Jun 30, 2022 | -33.81% |
| Mar 31, 2022 | -38.20% |
| Dec 31, 2021 | 3,229.76% |
| Sep 30, 2021 | -115.65% |
| Mar 31, 2021 | 23.73% |
| Dec 31, 2020 | -97.18% |
| Sep 30, 2020 | 91.65% |
| Mar 31, 2020 | 445.49% |
| Dec 31, 2019 | 277.65% |
| Sep 30, 2019 | 417.39% |
| Jun 30, 2019 | 506.03% |
| Mar 31, 2019 | -721.80% |